Alla Goldman Seiffert, acting director of 18F’s office of acquisition, said their mission is to help vendors spend less resources on the bidding process and more on the delivery.
Marlin McFate, federal chief technology officer at Riverbed Technologies, joins host John Gilroy on this week’s Federal Tech Talk to discuss how his company is helping federal agencies improve their IT compliance and make their digital systems more efficient. August 21, 2018
Engility CEO Lynn Dugle joins host John Gilroy on this week’s Federal Tech Talk to discuss innovation, agile software development, and a tool her company has developed to assist in understanding big data. July 24, 2018
Clay Buckley, president of Cause Network, discusses how his company uses technology and innovation to help charities gain funds and help people in need. Blockchain, among other technologies, are allowing donors to see exactly where their money is going in the charity of their choice.
Diva Nagula, founder and CEO of the Washington, D.C. franchise for IV Docs, discusses how his company is part of a new wave of on-demand medical services. Nagula explains how this new trend is helping usher in the future of personalized medicine.
Tami Howie, chief executive officer of the Maryland Tech Council, discusses how Maryland is shaping up to be a great opportunity for tech and biotech entrepreneurs, and how the Maryland Tech Council is paving the way forward for innovation.
Evan Burfield, co-founder of accelerator 1776 and current CEO of Union, discusses his latest book, “Regulatory Hacking.” The book explains how entrepreneurs can take a close look at the regulation-heavy areas of the market that are the most in need of innovation, and how to work their way into the fold.
But even if the ACA disappeared, the government would still have a giant footprint in health and disease research. The National Institutes of Health’s annual budget and what the Centers for Medicare and Medicaid Services pays out for kidney dialysis both equal about $35 billion.
Jeff Galvin, CEO and founder of American Gene Technologies, discusses how new technologies in the realm of gene therapy are able to use viruses to heal terminal illness. Galvin believes that, within the next ten years, a large swath of terminal cancers and monogenic diseases can be effectively treated with these methods.
The Smithsonian Institute’s Lemelson Center for the Study of Invention and Innovation in Washington plans to showcase examples of today’s most creative military inventions.